ImmunoGen Announces Oppenheimer 26th Annual Healthcare Conference Webcast

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that David Johnston, Executive Vice President and Chief Financial Officer, will present at the upcoming Oppenheimer 26th Annual Healthcare Conference. The presentation is scheduled for 2:45 pm ET on December 9, 2015.